Aakash Desai

Aakash Desai: All set to showcase exciting NSCLC and lung cancer research at ASCO Lung24

Aakash Desai, Assistant Professor at

” T-1 ASCO24

All set to showcase exciting NSCLC and lung cancer research!

Current updated management algorithm for NSCLC, with the addition of

  1. Periop Pembrolizumab
  2. Adjuvant Alectinib
  3. Osi/Chemo for EGFRm
  4. Ami/Chemo for EGFR Ex20ins
  5. Repotrectenib ROS1

All in <1 year! what else did we miss?

And some interesting studies being presented in each setting at ASCO24, with the LAURA in plenary- will it change SOC??”

No alternative text description for this image

No alternative text description for this image

Source: Aakash Desai/LinkedIn

Aakash Desai Adjuvant Alectinib ASCO24 ASCOLung24 EGFR Ex20ins EGFRm Lung cancer NSCLC O'Neal Comprehensive Cancer Center pembrolizumab Periop Pembrolizumab Repotrectenib ROS1